This growth is fueled by a rising prevalence of cancer, increasing R&D investments in oncology, and rapid advancements ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

The antibody market has become a cornerstone of modern biotechnology and pharmaceutical industries, underpinning a vast array of diagnostic and therapeutic applications. Antibodies, which are proteins ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

The partnership will include $105m upfront to Orionis, with the potential for further payments that could exceed $2bn.

South Korean drug maker Samsung BioLogics said on Thursday it plans to split its business into contract manufacturing and development companies, to help allay customer concerns about conflicts of ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

Merck offers a low 8.5x PE, a 4.3% yield, a robust drug pipeline, and resilient growth despite Gardasil headwinds and tariff ...

So, like, there was this panel discussion, right? It was called “Paths to Liquidity - Strategies for Adapting to Volatile ...

Robust governance is the cornerstone of sustainable business development. In 2024, Innovent further refined its ESG ...

Almost a third of Americans are more than a year behind in cancer screening, more than half of them because of out-of-pocket ...